These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


167 related items for PubMed ID: 16120542

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Estimation of radiation-induced cancer from three-dimensional dose distributions: Concept of organ equivalent dose.
    Schneider U, Zwahlen D, Ross D, Kaser-Hotz B.
    Int J Radiat Oncol Biol Phys; 2005 Apr 01; 61(5):1510-5. PubMed ID: 15817357
    [Abstract] [Full Text] [Related]

  • 3. Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review.
    Tubiana M.
    Radiother Oncol; 2009 Apr 01; 91(1):4-15; discussion 1-3. PubMed ID: 19201045
    [Abstract] [Full Text] [Related]

  • 4. Estimated risk for secondary cancer in the contra-lateral breast following radiation therapy of breast cancer.
    Johansen S, Danielsen T, Olsen DR.
    Acta Oncol; 2008 Apr 01; 47(3):391-6. PubMed ID: 18348001
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Dose-effect models for risk-relationship to cell survival parameters.
    Daşu A, Toma-Daşu I.
    Acta Oncol; 2005 Apr 01; 44(8):829-35. PubMed ID: 16332590
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Risk of a second malignant neoplasm after cancer in childhood treated with radiotherapy: correlation with the integral dose restricted to the irradiated fields.
    Nguyen F, Rubino C, Guerin S, Diallo I, Samand A, Hawkins M, Oberlin O, Lefkopoulos D, De Vathaire F.
    Int J Radiat Oncol Biol Phys; 2008 Mar 01; 70(3):908-15. PubMed ID: 18262102
    [Abstract] [Full Text] [Related]

  • 11. Risk of second primary cancer following prostate cancer radiotherapy: DVH analysis using the competitive risk model.
    Takam R, Bezak E, Yeoh EE.
    Phys Med Biol; 2009 Feb 07; 54(3):611-25. PubMed ID: 19124952
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Risk of second malignancies after prostate irradiation?
    Müller AC, Ganswindt U, Bamberg M, Belka C.
    Strahlenther Onkol; 2007 Nov 07; 183(11):605-9. PubMed ID: 17960335
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Preoperative radiation treatment for rectal cancer: comparison of target coverage and small bowel NTCP in conventional vs. 3D-conformal planning.
    Cella L, Ciscognetti N, Martin G, Liuzzi R, Punzo G, Solla R, Farella A, Salvatore M, Pacelli R.
    Med Dosim; 2009 Nov 07; 34(1):75-81. PubMed ID: 19181259
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Occurrence of second cancers in patients treated with radiotherapy for rectal cancer.
    Birgisson H, Påhlman L, Gunnarsson U, Glimelius B.
    J Clin Oncol; 2005 Sep 01; 23(25):6126-31. PubMed ID: 16135478
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions.
    Jones B.
    J Radiol Prot; 2009 Jun 01; 29(2A):A143-57. PubMed ID: 19454805
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.